Senate Judiciary Chairman Chuck Grassley of Iowa announced on Friday the introduction of a bill aimed at preventing opioid ...

FDA approves new type of non-opioid pain medication in two decades - The new drug will be many times more expensive than a ...

Vertex Pharmaceuticals won approval from the U.S. Food and Drug Administration for a non-opioid pain drug, clearing the way for the rollout of a product that has simultaneously sparked high hopes and ...

Federal officials approved a new pain pill designed to eliminate the risks of addiction and overdose associated with opioid ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Too much news to include below, ...

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.

It was given to people who had acute surgical pain from either abdominoplasty, also known as a tummy tuck, or bunion surgery.

The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction of a first-in-class non-opioi ...

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...